Pfizer Inc
(NEOE:ZPFE)
C$
9.93
(0%)
Market Cap: 56.60 Bil
Enterprise Value: 127.76 Bil
PE Ratio: 18.54
PB Ratio: 1.54
GF Score: 57/100 Pfizer Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024 / 11:00PM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Albert Bourla, Chairman and CEO of Pfizer. So Albert, Happy New Year. Thanks for joining us.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
Happy New Year.
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
I know you want to make some quick opening remarks, and then we'll jump right into the conversation from there.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
That will be fantastic. First of all, I was instructed that you should all read very carefully this statement here, Legal insist on that. But I wanted to make a few comments before we go into the questions.
So clearly, 2023 was not a good year for us. We missed our internal projections and also, we missed the expectations of The Street.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot